CHARGED ALPHA
Stock Detail
CL Unclassified Latest YouTube: Q1 2026

CL

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q1 2026
Podcast available
Yes
Current price
$90.61
+0.36 (+0.40%)
Trailing / Forward P/E
35.12x
Forward: 22.42x
Market cap / Volume
Volume:
Revenue / Earnings Growth
8.4%
Earnings: -5.9%
Margins
20.9% op
Gross: 60.1% · Net: 10.0%
Balance sheet
1.02x current
Debt / Equity: 1640.5
52-week range / Beta
$74.55 - $99.33
Beta: 0.30
Analyst target
$95.84
Upside: 5.8%
Cash / shareholder return
4.58% FCF yield
Dividend yield: 2.30%

Company context

Industry: Household & Personal Products
Country: United States
Employees:
Price to book: 500.61x
Return on equity: 363.6%
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Price chart

Market context for CL

Competitive view

CL vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

CL
CL
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
SS&C Technologies Holdings Inc.
SSNC
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Charles Schwab Corporation
SCHW
YouTube
Latest video
Q1 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
CL
$72.51B
CL
SSNC
$16.15B
SS&C Technologies Holdings Inc.
SCHW
$156.78B
Charles Schwab Corporation
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
CL
35.1x
CL
SSNC
20.8x
SS&C Technologies Holdings Inc.
SCHW
17.9x
Charles Schwab Corporation
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
CL
22.4x
CL
SSNC
8.9x
SS&C Technologies Holdings Inc.
SCHW
12.5x
Charles Schwab Corporation
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
CL
8.4%
CL
SSNC
8.8%
SS&C Technologies Holdings Inc.
SCHW
15.8%
Charles Schwab Corporation
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
CL
-5.9%
CL
SSNC
8.3%
SS&C Technologies Holdings Inc.
SCHW
38.6%
Charles Schwab Corporation
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
CL
20.9%
CL
SSNC
24.2%
SS&C Technologies Holdings Inc.
SCHW
49.4%
Charles Schwab Corporation
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
CL
60.1%
CL
SSNC
48.0%
SS&C Technologies Holdings Inc.
SCHW
97.5%
Charles Schwab Corporation
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
CL
10.0%
CL
SSNC
12.7%
SS&C Technologies Holdings Inc.
SCHW
38.0%
Charles Schwab Corporation
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
CL
363.6%
CL
SSNC
11.8%
SS&C Technologies Holdings Inc.
SCHW
19.1%
Charles Schwab Corporation
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
CL
4.6%
CL
SSNC
7.9%
SS&C Technologies Holdings Inc.
SCHW
6.2%
Charles Schwab Corporation
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
CL
1640.54x
CL
SSNC
110.67x
SS&C Technologies Holdings Inc.
SCHW
120.77x
Charles Schwab Corporation
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
CL
1.02x
CL
SSNC
1.10x
SS&C Technologies Holdings Inc.
SCHW
0.63x
Charles Schwab Corporation
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
CL
0.30
CL
SSNC
1.12
SS&C Technologies Holdings Inc.
SCHW
0.80
Charles Schwab Corporation
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
CL
2.3%
CL
SSNC
1.6%
SS&C Technologies Holdings Inc.
SCHW
1.2%
Charles Schwab Corporation
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
CL
5.8%
CL
SSNC
41.4%
SS&C Technologies Holdings Inc.
SCHW
28.5%
Charles Schwab Corporation

Episode timeline

Episode archive for CL

Each row is one earnings episode with every verified platform link available.

Q1 2026
Episode live
Published youtube podcast complete
CL Stock: Q1 2026 Earnings Analysis
Quarterly earnings-analysis entry for CL. Use the links on the right to open the video or podcast episode.